Xvivo Perfusion AB's total assets for Q2 2025 were kr2.39B, an increase of 4.02% from the previous quarter. XVIPF total liabilities were kr295.46M for the fiscal quarter, a 45.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.